Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT(5A) receptor antagonistic activity

European Journal of Pharmacology

Volumn 329, Issue 1, 1997, Pages 27-35

  Takeuchi, Hiromi ^a   Yatsugi, Shin ichi ^a   Hatanaka, Ken ichi ^a   Nakato, Kazuhiro ^a   Hattori, Hanae ^a   Sonoda, Rie ^a   Koshiya, Kazuo ^a   Fujii, Mitsuo ^a   Yamaguchi, Tokio ^a  

^a Neuroscience Research   (Japan)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) re uptake inhibition; 5 HT(2A) receptor antagonistic activity; Antidepressant; Olfactory bulbectomized rat; Tail suspension test; YM992

Indexed keywords

2 [[(7 FLUORO 4 INDANYL)OXY]METHYL]MORPHOLINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYTRYPTOPHAN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; NEW DRUG; OXOTREMORINE; PHENYLEPHRINE; SEROTONIN 2A ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; HEAD TWITCH; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEARNING DISORDER; MALE; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; ORAL DRUG ADMINISTRATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONIN UPTAKE; TAIL; TREMOR;

EID: 0031577189     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)10108-X     Document Type: Article

References (28)

1. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;46-58.
2. 1A receptors. Br. J. Pharmacol. 100:1990;793-799.
3. Blier P., De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:1994;220-225.
4. Blier P., De Montigny C., Chaput Y. A role for the serotonin system in the mechanism of action of antidepressants. J. Clin. Psychiatry. 51(Suppl. 1):1990;14-20.
5. Bogdanski D.F., Weissbach H., Udenfriend S. Pharmacological studies with the serotonin precursor, 5-hydroxytryptophan. J. Pharmacol. Exp. Ther. 122:1958;182-194.
6. Cairncross K.D., Cox B., Forster C., Wren A.F. A new model for the detection of antidepressant drugs: olfactory bulbectomy in the rat compared with exiting models. J. Pharmacol. Methods. 1:1978;131-143.
7. Cairncross K.D., Wren A., Foster C., Cox B., Schnieden H. The effect of psychoactive drugs on plasma corticosterone levels and behavior in the bulbectomized rat. Pharmacol. Biochem. Behav. 10:1979;353-359.
8. Chaput Y., De Montigny C., Blier P. Presynaptic and postsynaptic modification of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat. Neuropsychopharmacology. 5:1991;219-229.
9. Cowen P.J. Antidepressant: current concepts of mode of action. Int. Clin. Psychopharmacol. 5(Suppl. 3):1990;45-55.
10. Cowen P.J. Serotonin receptor subtypes: implications for psychopharmacology. Br. J. Psychiatry. 159(Suppl. 12):1991;7-14.
11. 1C-mediated phenomenon. Pharmacol. Biochem. Behav. 48:1994;383-396.
12. 2A receptor antagonistic activity. Psychopharmacology. 35:1996;1621-1626.
13. 1A receptors in the rat hippocampus. Biog. Amines. 9:1993;295-306.
14. Honda K., Nakagawa C., Inagaki O., Shibasaki M., Takenaka T., Takeda M. Adrenoceptor blocking and cardiovascular effects of the optical isomers of amosulalol (YM-09538), a combined α-and β-adrenoceptor blocking agent, and the corresponding deoxy derivative (YM-11133) in rats. Jpn. J. Pharmacol. 41:1986;459-466.
15. 2 receptors in rat brain: an autoradiographic study. Synapse. 14:1993;324-331.
16. Janscar S.M., Leonard B.E. The effects of antidepressant drugs on conditioned taste of aversion learning of the olfactory bulbectomized rat. Neuropharmacology. 20:1981;1341-1345.
17. Jesberger J.A., Richardson J.S. Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats. Behav. Neurosci. 100:1986;256-274.
18. Johnson, A.M., 1991. The comparative pharmacological properties of selective serotonin re-uptake inhibitors in animals. In: Feighner, J.P., Boyer, W.F. (Eds.), Selective Serotonin Re-uptake Inhibitors. John Wiley&Sons, Chichester, pp. 37-70.
19. Lakoski J.M., Aghajanian G.K. Effects of ketanserin on neuronal responses to serotonin in the prefrontal cortex, lateral geniculate and dorsal raphe nucleus. Neuropharmacology. 24:1985;265-273.
20. Leonard B.E. Mechanisms of action of antidepressants. CNS Drugs. 4:1995;1-12.
21. 1A receptor responsivity in unipolar depression: evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychiatry. 28:1990;620-628.
22. Lucki I., Nobler M.S., Frazer A. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J. Pharmacol. Exp. Ther. 228:1984;133-139.
23. Mann J.J., Arango V., Underwood D. Serotonin and suicidal behavior. Ann. NY Acad. Sci. 600:1990;476-484.
24. Neckers L.M., Zarrow M.X., Myers M.M., Denenberg V.H. Influence of olfactory bulbectomy and the serotonergic system upon intermale aggression and maternal behavior in the mouse. Pharmacol. Biochem. Behav. 3:1975;545-550.
25. Riblet L.A., Gatewood C.F., Mayol R.F. Comparative effects of trazodone and tricyclic antidepressants on uptake of selected neurotransmitters by isolate rat brain synaptosomes. Psychopharmacology. 63:1979;99-101.
26. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 85:1985;367-370.
27. 1 receptors mediate inhibition of cyclic AMP production in neurons. Eur. J. Pharmacol. 120:1986;230-277.
28. 1A receptors in rat brain following antidepressant drug treatment. Synapse. 4:1989;347-352.